ArticleTherapeutic advances in gastroenterology2023

Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing.

Federico Argüelles-Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.